Priming with ligands secreted by human stromal progenitor cells promotes grafts of cardiac stem/progenitor cells after myocardial infarction

Stem Cells

Volumn 32, Issue 3, 2014, Pages 674-683

  Iso, Yoshitaka ^a   Rao, Krithika S ^a   Poole, Charla N ^b   Zaman, A K M Tarikuz ^a   Curril, Ingrid ^a   Sobel, Burton E ^a   Kajstura, Jan ^c   Anversa, Piero ^c   Spees, Jeffrey L ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CSCs CPCs; CTGF; Insulin; MSCs; Paracrine; Progenitor cells; Stem cells; Stromal cells

Indexed keywords

CSCS/CPCS; CTGF; INSULIN; MSCS; PARACRINE; PROGENITOR CELLS; STEM CELLS; STROMAL CELLS;

ADULT; ANIMALS; CATTLE; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; CULTURE MEDIA, CONDITIONED; ENZYME ACTIVATION; HUMANS; INFUSIONS, INTRA-ARTERIAL; INSULIN; LIGANDS; MULTIPOTENT STEM CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; STAT3 TRANSCRIPTION FACTOR; STEM CELL TRANSPLANTATION; STEM CELLS; STROMAL CELLS;

EID: 84894277667     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1546     Document Type: Article

References (45)

1. Mohsin S, Siddiqi S, Collins B, et al. Empowering adult stem cells for myocardial regeneration. Circ Res 2011; 109: 1415-1428.
2. Shimada IS, Spees JL,. Stem and progenitor cells for neurological repair: Minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J Cell Biochem 2011; 112: 374-380.
3. Robey TE, Saiget MK, Reinecke H, et al. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008; 45: 567-581.
4. Segers VF, Lee RT,. Biomaterials to enhance stem cell function in the heart. Circ Res 2011; 109: 910-922.
5. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003; 9: 1195-1201.
6. Kinnaird T, Stabile E, Burnett MS, et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004; 94: 678-685.
7. Gnecchi M, Zhang Z, Ni A, et al. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
8. Ding L, Saunders TL, Enikolopov G, et al. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457-462.
9. Méndez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010; 466: 829-834.
10. Sacchetti B, Funari A, Michienzi S, et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007; 131: 324-336.
11. Stier S, Ko Y, Forkert R, et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005; 201: 1781-1791.
12. Dexter TM, Allen TD, Lajtha LG,. Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 1977; 91: 335-344.
13. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-921.
14. Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-835.
15. Richards M, Fong CY, Chan WK, et al. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002; 20: 933-936.
16. Quirici N, Soligo D, Bossolasco P, et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol 2002; 30: 783-791.
17. Cattoretti G, Schiro R, Orazi A, et al. Bone marrow stroma in humans: Anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993; 81: 1726-1738.
18. Bakondi B, Shimada IS, Perry A, et al. CD133 identifies a human bone marrow stem/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 2009; 17: 1938-1947.
19. Kuçi S, Kuçi Z, Kreyenberg H, et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica 2010; 95: 651-659.
20. + mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction. Stem Cells Trans Med 2012; 1: 462-468.
21. Niwa H, Burdon T, Chambers I, et al. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev 1998; 12: 2048-2060.
22. Chung YJ, Park BB, Kang YJ, et al. Unique effects of Stat3 on the early phase of hematopoietic stem cell regeneration. Blood 2006; 108: 1208-1215.
23. Yoshimatsu T, Kawaguchi D, Oishi K, et al. Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex. Development 2006; 133: 2553-2563.
24. Pirkmajer S, Chibalin AV,. Serum starvation: Caveat emptor. Am J Physiol Cell Physiol 2011; 301: C272-279.
25. DeBosch BJ, Muslin AJ,. Insulin signaling pathways and cardiac growth. J Mol Cell Cardiol 2008; 44: 855-864.
26. Padin-Iruegas ME, Misao Y, Davis ME, et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009; 120: 876-887.
27. Hatzistergos KE, Quevedo H, Oskouei BN, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010; 107: 913-922.
28. Steffen CL, Ball-Mirth DK, Harding PA, et al. Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 1998; 15: 199-213.
29. Gao R, Brigstock DR,. Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 2004; 279: 8848-8855.
30. Kim HW, Haider HK, Jiang S, et al. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J Biol Chem 2009; 284: 33161-33168.
31. Pasha Z, Wang Y, Sheikh R, et al. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc Res 2008; 77: 134-142.
32. Lu G, Haider HK, Jiang S, et al. Sca-1+ stem cell survival and engraftment in the infarcted heart: Dual role for preconditioning-induced connexin-43. Circulation 2009; 119: 2587-2596.
33. Kofidis T, de Bruin JL, Yamane T, et al. Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury. Circulation 2005; 111: 2486-2493.
34. Kofidis T, de Bruin JL, Yamane T, et al. Insulin-like growth factor promotes engraftment, differentiation, and functional improvement after transfer of embryonic stem cells for myocardial restoration. Stem Cells 2004; 22: 1239-1245.
35. Martinez EC, Wang J, Gan SU, et al. Ascorbic acid improves embryonic cardiomyoblast cell survival and promotes vascularization in potential myocardial grafts in vivo. Tissue Eng Part A 2010; 16: 1349-1361.
36. Spees JL, Gregory CA, Singh H, et al. Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Mol Ther 2004; 9: 747-756.
37. Shimo T, Nakanishi T, Nishida T, et al. Connective tissue growth factor induces the proliferation, migration, and tube formation of vascular endothelial cells in vitro, and angiogenesis in vivo. J Biochem 1999; 126: 137-145.
38. Pi L, Shenoy AK, Liu J, et al. CCN2/CTGF regulates neovessel formation via targeting structurally conserved cystine knot motifs in multiple angiogenic regulators. FASEB J 2012; 26: 3365-3379.
39. Grotendorst GR, Rahmanie H, Duncan MR,. Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 2004; 18: 469-479.
40. Grotendorst GR, Duncan MR,. Individual domains of connective tissue growth factor regulate fibroblast proliferation and myofibroblast differentiation. FASEB J 2005; 19: 729-738.
41. Guney MA, Petersen CP, Boustani A, et al. Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells. Proc Natl Acad Sci USA 2011; 108: 15242-15247.
42. Ohnishi H, Oka T, Kusachi S, et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 1998; 30: 2411-2422.
43. Segarini PR, Nesbitt JE, Li D, et al. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 2001; 276: 40659-40667.
44. Mercurio S, Latinkic B, Itasaki N, et al. Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development 2004; 131: 2137-2147.
45. Wahab NA, Weston BS, Mason RM,. Connective tissue growth factor CCN2 interacts with and activates the tyrosine kinase receptor TrkA. J Am Soc Nephrol 2005; 16: 340-351.